Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Cross Country Healthcare, Inc. (NASDAQ:CCRNGet Free Report) have earned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $28.00.

Several brokerages recently issued reports on CCRN. StockNews.com began coverage on Cross Country Healthcare in a research note on Thursday, October 5th. They set a “hold” rating on the stock. Truist Financial reduced their price objective on Cross Country Healthcare from $25.00 to $22.00 and set a “hold” rating on the stock in a research note on Friday, November 3rd. Barrington Research reduced their price objective on Cross Country Healthcare from $35.00 to $29.00 and set an “outperform” rating on the stock in a research note on Monday, August 14th. Credit Suisse Group reduced their price objective on Cross Country Healthcare from $27.00 to $26.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 8th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $21.00 target price (down from $32.00) on shares of Cross Country Healthcare in a research report on Friday, November 3rd.

View Our Latest Analysis on Cross Country Healthcare

Insiders Place Their Bets

In other news, insider Marc S. Krug sold 6,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $19.91, for a total transaction of $119,460.00. Following the transaction, the insider now directly owns 39,387 shares of the company’s stock, valued at $784,195.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, VP Cynthia Ann Grieco sold 6,370 shares of the firm’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $20.60, for a total transaction of $131,222.00. Following the transaction, the vice president now directly owns 7,464 shares of the company’s stock, valued at $153,758.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Krug sold 6,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $19.91, for a total value of $119,460.00. Following the transaction, the insider now directly owns 39,387 shares in the company, valued at $784,195.17. The disclosure for this sale can be found here. 5.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. US Bancorp DE bought a new position in Cross Country Healthcare during the first quarter valued at about $27,000. Quadrant Capital Group LLC bought a new position in Cross Country Healthcare during the second quarter valued at about $29,000. Point72 Hong Kong Ltd bought a new position in Cross Country Healthcare during the first quarter valued at about $35,000. Coppell Advisory Solutions Corp. bought a new position in Cross Country Healthcare during the fourth quarter valued at about $39,000. Finally, Captrust Financial Advisors boosted its stake in Cross Country Healthcare by 26.4% during the first quarter. Captrust Financial Advisors now owns 3,074 shares of the business services provider’s stock valued at $67,000 after buying an additional 642 shares in the last quarter. Institutional investors own 96.03% of the company’s stock.

Cross Country Healthcare Trading Up 4.3 %

Cross Country Healthcare stock opened at $21.39 on Tuesday. The stock has a market cap of $751.86 million, a P/E ratio of 7.59, a price-to-earnings-growth ratio of 1.53 and a beta of 1.03. The stock has a 50 day moving average of $22.60 and a 200-day moving average of $24.67. Cross Country Healthcare has a 52 week low of $15.65 and a 52 week high of $36.90.

Cross Country Healthcare (NASDAQ:CCRNGet Free Report) last released its earnings results on Wednesday, November 1st. The business services provider reported $0.39 EPS for the quarter, missing the consensus estimate of $0.41 by ($0.02). Cross Country Healthcare had a net margin of 4.58% and a return on equity of 23.60%. The business had revenue of $442.29 million for the quarter, compared to analysts’ expectations of $443.90 million. During the same quarter last year, the company posted $1.07 earnings per share. The business’s quarterly revenue was down 30.5% compared to the same quarter last year. As a group, equities analysts predict that Cross Country Healthcare will post 2.24 earnings per share for the current fiscal year.

About Cross Country Healthcare

(Get Free Report

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; managed services programs services; education healthcare services; in-home care services; and outsourcing services.

Featured Stories

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.